Introduction
leading specialty pharmaceutical company entered an in-licensing agreement for Semaglutide to market the diabetes therapy across Africa, the Middle East, and Central Asia after regulatory approvals.
Also Read: Royal India Corp shares rise 9% on signing MoU with JSC ETC GET
Share price movement of Ajanta Pharma
On December 24, 2025, Ajanta Pharma Ltd opened at ₹2,736.20, up 2.62% from its previous close of ₹2,666.45. The stock touched a high of ₹2,820.00 (5.76%) and a low of ₹2,736.20 (2.62%). By 1:31 PM, it traded at ₹2,748.10, a 3.06% increase, with a market cap of ₹34,333.56 crore.
Ajanta Pharma Signs Semaglutide Deal
Ajanta Pharma Ltd announced an in-licensing agreement with Biocon Ltd for Semaglutide. Biocon will supply the product for exclusive and semi-exclusive marketing across 26 countries.
The agreement covers 23 countries with exclusive rights and three countries with semi-exclusive rights across Africa, the Middle East and Central Asia. Semaglutide is a GLP-1 receptor agonist.
Product patents expire in most markets by March 2026. Ajanta plans commercialization after regulatory approvals expected in late 2026 or early 2027 across the covered regions.
Stock performance of Ajanta Pharma for Period of 1 week, 6 months, and 1 year
Ajanta Pharma Ltd delivered a 2.61% return over the past week. The stock rose 5.85% over the past six months. It declined 4.84% over the past year.
Also Read: HCLtech arm to acquire Jaspersoft from Cloud Software Group
Shareholding pattern of Ajanta Pharma
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
| Promoter | 66.30% | 66.30% | 66.30% |
| FII | 8.50% | 8.90% | 8.90% |
| DII | 17.90% | 17.50% | 17.50% |
| Public | 7.30% | 7.40% | 7.40% |
About Ajanta Pharma
Ajanta Pharma Ltd (NSE: AJANTPHARM) is a specialty pharmaceutical company focused on branded generics across India, Asia, and Africa, with presence in the US, strong R&D capabilities, and multiple manufacturing facilities in India.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Ajanta Pharma Ltd share price going up today?
A: Ajanta Pharma Ltd share price rose after signing an in-license agreement with Biocon for Semaglutide marketing across 26 countries.
Q: What does Ajanta Pharma Ltd specialize in?
A: Ajanta Pharma Ltd specializes in branded generic pharmaceutical formulations across cardiology, antidiabetic, ophthalmology, and other therapeutic segments.
Q: What is the market capitalization of Ajanta Pharma Ltd?
A: Ajanta Pharma Ltd has a market capitalization of about ₹34,333.56 crore as of December 24, 2025.
